Nature, Published online: 17 September 2025; doi:10.1038/d41586-025-03001-y

Merck and AstraZeneca say the United Kingdom is not spending enough on medicines, but experts say it’s a symptom of underlying weaknesses in the global pharmaceutical sector.


From Nature via this RSS feed